HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Unexpected alterations in fentanyl pharmacokinetics in children undergoing cardiac surgery: age related or disease related?

Abstract
We assessed the pharmacokinetics of fentanyl in 19 infants and children undergoing cardiac surgery for correction of tetralogy of Fallot, A-V-canal and transposition of the great arteries. Distribution T1/2 (10.2 +/- 2.4 min) and total body clearance (13.3 +/- 6.5 ml/kg/min) were similar to adult values. An elimination t1/2 (102 +/- 85 min) shorter than in adults is readily explained by the significantly smaller distribution volume of the drug (1,203 +/- 777 ml/kg). Good correlation was found between distribution volume (Vss) and elimination t1/2 (r = 0.86, p less than 0.01) and between Vss and age of patients with tetralogy of Fallot (r = 0.85, p less than 0.01). However, older children with Fallot's had higher values of PO2 due to a milder condition (r = 0.89, p less than 0.01); consequently PO2 correlated positively with Vss (r = 0.76, p = 0.05). Fentanyl total body clearance (TBC) tends to decrease with age in these patients (r = 0.66, p = 0.05) similar to noncardiac children. Our studies suggest that the alterations in the distribution volume of fentanyl in these children may largely depend upon the severity of the hemodynamic disturbance whereas TBC of the drug may depend on their age.
AuthorsG Koren, G Goresky, P Crean, J Klein, S M MacLeod
JournalDevelopmental pharmacology and therapeutics (Dev Pharmacol Ther) Vol. 9 Issue 3 Pg. 183-91 ( 1986) ISSN: 0379-8305 [Print] Switzerland
PMID3709338 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Oxygen
  • Fentanyl
Topics
  • Adolescent
  • Aging
  • Child
  • Child, Preschool
  • Endocardial Cushion Defects (blood)
  • Fentanyl (blood)
  • Half-Life
  • Heart Defects, Congenital (blood, surgery)
  • Humans
  • Infant
  • Kinetics
  • Oxygen (blood)
  • Tetralogy of Fallot (blood)
  • Transposition of Great Vessels (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: